| Literature DB >> 24722663 |
Sergey Burnos1, Peter Hilfiker2, Oguzkan Sürücü3, Felix Scholkmann4, Niklaus Krayenbühl3, Thomas Grunwald5, Johannes Sarnthein6.
Abstract
OBJECTIVES: High frequency oscillations (HFOs) have been proposed as a new biomarker for epileptogenic tissue. The exact characteristics of clinically relevant HFOs and their detection are still to be defined.Entities:
Mesh:
Year: 2014 PMID: 24722663 PMCID: PMC3983146 DOI: 10.1371/journal.pone.0094381
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Clinical data and implantation sites.
| Patient | Age | Age at onset | MRI | Histology | Number of implanted electrodes | Implantation sites | Procedure |
| 1 | 21 | 2 | HS (left MTL) | HS type 1a | 8 | AL, ECL, HL, PCL AR, ECR, HR, PCR | sAHE |
| 2 | 21 | 3 | HS (left MTL) & right frontal FCD | – | 7 | AL, ECL, HL, PH ECR, HR, PCR | DBS |
| 3 | 34 | 25 | bilateral HS | – | 5 | ECL, HL AR, ECR, HR | DBS |
| 4 | 48 | 2 | HS (left MTL) | HS (no classification) | 8 | AL, ECL, HL, PCL AR, ECR, HR, PCR | sAHE |
| 5 | 27 | 1 | right frontal FCD | FCD type IIa | 3 | FAR, TFR, FPR | LE |
| 6 | 22 | 11 | no lesion | – | 5 | TLL, TBAL, TBPL TBAL, TBPR | – |
Pathologies: FCD focal cortical dysplasia; HS hippocampal sclerosis. Procedures: DBS deep brain stimulation; LE extended lesionectomy; sAHE selective amygdala-hippocampectomy. Implantation sites: AL amygdala left; AR amygdala right; EL entorhinal cortex left; ER entorhinal cortex right; FAR frontal anterior right; FL frontal lobe; FPR frontal posterior right; HL hippocampus left; HR hippocampus right; MTL mesial temporal lobe; PL perirhinal cortex left; PR perirhinal cortex right; TBAL temporal basal anterior left; TBAR temporal basal anterior right; TBPL temporal basal posterior left; TBPR temporal basal posterior right; TR depth frontal right; TLL temporal lateral left.
Figure 1HFO in a temporomesial recording.
(A) Raw iEEG 10 s epoch from channel HL1 in patient 1. (B) Raw iEEG at extended time scale of 500 ms. (C) Filtered iEEG of panel B with envelope (red line). The envelope satisfies the criteria for an EoI (Stage 1 of detection). The peak of the envelope is marked by dashed vertical lines in panels A, B and C. (D) Time frequency representation of the iEEG of panel B. The circle marks the peak of the envelope of the EoI. The “blob” represents the HFO. (E) Power spectral density (PSD, unit: 10log10μV2Hz−1) at the peak of the EoI. For the event illustrated here, there is a HFO peak at 116 Hz, a trough at 73 Hz and a low frequency peak at 47 Hz. The thin line shows the PSD of the same data calculated by the short-time Fast Fourier Transform for comparison.
Figure 2Sharp artifact.
(A) Raw iEEG data 10 s epoch from a frontal channel in patient 6. (B) Raw iEEG at extended time scale. (C) Filtered data (blue line) with envelope (red line). The envelope satisfies the criteria for an EoI (Stage 1 of detection). While the high-frequency activity is separated by a trough (D, E), it is excluded from acceptance as HFO because the peak of the spectral power appears at frequencies above 500 Hz.
Spatial HFO distribution compared to seizure onset zone (SOZ).
| Patient | HFO area [number of channels] | HFO area [% of all channels] | Channels within HFO area | Seizure onset zone (SOZ) | TP | TN | FP | FN | Sens | Spec |
| 1 | 6 | 11% | HL 1, 6; PL 1, 2; ER 1, 2 | HL 1, 2 | 1 | 49 | 5 | 1 | 50% | 91% |
| 2 | 3 | 60% | HL 7; HR 2; ER 7 | HL 1; EL 1; HR 1, 2, 3; ER 1, 2 | 1 | 40 | 2 | 6 | 14% | 95% |
| 3 | 5 | 14% | HL 1; HR 1, 2; AR 1, 2 | HL 1, 2; AR 1, 2 | 3 | 29 | 2 | 1 | 75% | 94% |
| 4 | 6 | 11% | EL 1, 2; PL 1; HL 1; PR 1; AR 1 | EL 1,2; HL 1,2 | 3 | 49 | 3 | 1 | 75% | 94% |
| 5 | 29 | 74% | FPR 2, 3, 4, 5, 6, 8, 9, 10, 11, 12, 13, 14, 15; FAR 4, 5, 6, 7, 10, 11, 12, 13, 14; TR 1, 2, 3, 4, 5, 6, 7 | FPR 1, 2, 3, 4, 9, 10, 11, 12; FAR 5, 6, 13, 14; TR 1, 2, 3, 4 | 15 | 9 | 14 | 1 | 94% | 39% |
| 6 | 2 | 6% | TLL 28, 29 | TLL 18, 19, 20, 21, 22, 23, 26, 27, 28, 29, 30, 31 TBAL 1, 2, 3 | 2 | 24 | 0 | 13 | 13% | 100% |
Channels with high number of HFOs define the HFO area with a threshold determined by a half maximum. HFO areas and SOZ show partial overlap in all 6 patients. Channel HL1 indicates a bipolar recording from contacts HL2-HL1. For abbreviations of electrode names, see Table 1.
Figure 3Interictal Epileptiform Spike (IES) without HFO.
(A) Raw iEEG 10 s epoch from channel HL6 in patient 1. (B) Raw iEEG at extended time scale of 500 ms. (C) Filtered iEEG of panel B with envelope (red line). The envelope satisfies the criteria for an EoI (Stage 1 of detection). (D, E) The peak of the high-frequency activity and the trough coincide at 60 Hz, i.e. the EoI is not separated from low-frequency activity by a trough and the EoI is therefore excluded from acceptance as HFO.
Figure 4HFO with frequency peak below 80 Hz.
(A) Raw iEEG data 10 s epoch from channel HL6 in patient 1. (B) Raw iEEG at extended time scale of 500 ms. (C) Filtered iEEG with envelope (red line). The envelope satisfies the criteria for an EoI (Stage 1 of detection). The EoI is salient enough to be separated from low-frequency activity by a trough (D, E). This EoI has the visual appearance of a HFO but the peak frequency is around 60 Hz. Therefore, in Stage 2 the lowest boundary for a HiFP was chosen at 60 Hz and this EoI was accepted as HFO by our detector.
Figure 5HFO in a neocortical recording.
(A) Raw iEEG data 10 s epoch recorded from a frontal channel in patient 6. (B) Raw iEEG at extended time scale of 500 ms. (C) Filtered data with envelope (red line). The envelope satisfies the criteria for an EoI. The peak of the envelope is marked by dashed vertical lines in panels A, B and C. (D) Time frequency representation of the iEEG of panel B. The circle marks the peak of the envelope of the EoI. (E) Power spectral density (PSD, unit: 10log10μV2Hz−1) at the peak of the envelope. The high frequency peak is at 82 Hz, the trough at 40 Hz and the low frequency peak at 30 Hz for this event, which was accepted as HFO in Stage 2 of the detection.
Temporal and spectral characteristics of HFOs in individual patients.
| Patient | Number of channels | Number of EoIs | Number of HFOs | Acceptance rate [%] | Number of ripples/fast ripples # ripple/# FR | HFO rate per channel, mean±SD [1/min] | HFO duration, mean±SD [ms] | HFO peak, mean±SD [Hz] | Trough frequency, mean±SD [Hz] | Low frequency peak, mean±SD [Hz] | Amplitude, mean±SD [μV] |
| 1 | 56 | 796 | 378 | 47% | 337/41 | 7 ± 11 | 58 ± 34 | 113 ± 55 | 58 ± 20 | 39 ± 18 | 16 ± 26 |
| 2 | 49 | 245 | 91 | 37% | 77/14 | 2 ± 4 | 47 ± 26 | 141 ± 78 | 57 ± 19 | 39 ± 17 | 77 ± 114 |
| 3 | 35 | 882 | 387 | 44% | 292/95 | 11 ± 23 | 41 ± 15 | 159 ± 90 | 71 ± 33 | 42 ± 26 | 57 ± 40 |
| 4 | 56 | 1013 | 323 | 32% | 317/6 | 1 ± 9 | 58 ± 25 | 93 ± 30 | 56 ± 16 | 38 ± 13 | 20 ± 22 |
| 5 | 39 | 3724 | 3104 | 83% | 3104/0 | 80 ± 29 | 91 ± 48 | 94 ± 16 | 52 ± 11 | 37 ± 12 | 82 ± 61 |
| 6 | 36 | 576 | 457 | 79% | 457/0 | 13 ± 19 | 67 ± 48 | 82 ± 16 | 51 ± 11 | 37 ± 10 | 21 ± 11 |
For each patient we present the total number of EoIs detected in Stage 1 and the number of HFOs accepted in Stage 2. Based on their peak frequency, HFOs were then classified into ripples (80–200 Hz) and FRs (200–500 Hz).
Figure 6Fast ripple in a temporomesial recording.
(A) Raw iEEG data 10 s epoch recorded from channel AR1 in patient 3. (B) Raw iEEG at extended time scale of 500 ms. (C) Filtered data with envelope (red line). The envelope satisfies the criteria for an EoI. The peak of the envelope is marked by dashed vertical lines in panels A, B and C. (D) Time frequency representation of the iEEG of panel B. The circle marks the peak of the envelope of the EoI. (E) Power spectral density (PSD, unit: 10log10μV2Hz−1) at the peak of the envelope. The high frequency peak is at 292 Hz, the trough at 192 Hz and the low frequency peak at 153 Hz for this event, which was accepted as a FR in Stage 2 of the detection.
Figure 7Channels ranked by HFO rate.
Channels with high HFO rate are assumed to mark the epileptogenic zone. Channels with HFO rate above the half maximum (black bars) constitute the HFO area. The channel locations of the HFO area in each patient is given in Table 3.
Figure 8HFO peak frequency distribution.
(A) Total of all HFOs recorded from the four patients with temporomesial electrodes (N = 1179). The sharp edge to low frequencies stems from the frequency threshold of 60 Hz of the detector. (B) Total of all HFOs recorded from the two patients with neocortical electrodes (N = 3561). The distributions are fitted with a lognormal function (red line). The frequency peaks of HFOs from temporomesial recordings are more widely distributed than those from neocortical recordings.
Comparison to existing detectors.
| Patient | Our detector | RMS detector | LineLength detector | |||||||||
| Sens [%] | CI [%] | Spec [%] | CI [%] | Sens [%] | CI [%] | Spec [%] | CI [%] | Sens [%] | CI [%] | Spec [%] | CI [%] | |
| 1 | 50 | 13–99 | 91 | 80–97 | 50 | 13–99 | 91 | 80–97 | 50 | 13–99 | 94 | 85–99 |
| 2 | 14 | 0–64 | 95 | 84–99 | 0 | 0–40 | 95 | 84–99 | 0 | 0–40 | 95 | 84–99 |
| 3 | 75 | 19–99 | 94 | 79–99 | 50 | 7–93 | 97 | 83–100 | 50 | 7–93 | 94 | 79–99 |
| 4 | 75 | 19–99 | 94 | 84–99 | 0 | 0–60 | 98 | 90–100 | 25 | 1–81 | 98 | 90–100 |
| 5 | 94 | 70–100 | 39 | 35–87 | 69 | 41–89 | 52 | 31–73 | 81 | 54–96 | 61 | 39–80 |
| 6 | 13 | 2–40 | 100 | 86–100 | 13 | 2–40 | 100 | 86–100 | 13 | 2–40 | 100 | 86-100 |
We defined the HFO area by the half maximum method for all three detectors. Sens – sensitivity, spec – specificity and CI – confidence intervals as defined in section “Statistical analysis”.